Trial intelligence / Profile preview

Effect of different dexmedetomidine administration methods on hemodynamic responses to laryngoscopy

IRCT20141001019359N15Phase 3Completed

Sponsor
North Khorasan University of Medical Sciences
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine (3 arms), sponsored by North Khorasan University of Medical Sciences. Started Nov 2022; status: completed.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on IRCT20141001019359N15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141001019359N15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call